Hovione FarmaCiencia SA (Hovione) is a pharmaceutical contract development and manufacturing organisation (CDMO) specialising in drug manufacturing and particle engineering services.

Founded in Portugal, Hovione provides a comprehensive suite of pharmaceutical services, including the production of active pharmaceutical ingredients (APIs) and drug products. The company focuses on advanced particle engineering technologies, such as spray drying, to enhance drug solubility and bioavailability. With state-of-the-art manufacturing facilities in Portugal, Macau, Ireland, and the United States, Hovione caters to clients globally, combining innovative solutions with operational excellence.

Key Products and Services:

• Analytical Support: Comprehensive analytical testing for pharmaceutical products.
• Formulation Services: Generic deformulation, formulation, blending, and device integration.
• Contract Drug Manufacturing:
  • API manufacturing (chemical and biological).
  • Clinical and commercial dose production (solid and other dosage forms).
  • Spray drying, hot melt extrusion, and spray congealing.
  • Continuous tableting and precision capsule filling.
• Drugs Development: Jet milling, wet polishing, and biorelevant analytical testing.

Headquartered in Loures, Portugal, Hovione leverages over 65 years of industry expertise to provide end-to-end pharmaceutical solutions. Through its innovative technologies and unwavering focus on quality, the company remains committed to addressing complex drug development challenges and improving global patient outcomes.

Hovione continues to set the benchmark in the pharmaceutical industry with its extensive capabilities and commitment to excellence. For additional information about Hovione, please visit hovione.com.